INS and type 1 diabetes mellitus: Conversely, Pitocco et al. [56] revealed that 1-year supplementation with 1,25(OH)2D (0.25 μg/48 h) reduced insulin doses at 3 and 6 months but did not affect C-peptide or HbA1c levels in patients with T1DM.